210 related articles for article (PubMed ID: 9361395)
1. Role, control and expression of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase activities in human breast cancer.
Pasqualini JR
Zentralbl Gynakol; 1997; 119 Suppl 2():48-53. PubMed ID: 9361395
[TBL] [Abstract][Full Text] [Related]
2. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
3. Estrone sulfate-sulfatase and 17 beta-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence.
Pasqualini JR; Chetrite G; Nguyen BL; Maloche C; Delalonde L; Talbi M; Feinstein MC; Blacker C; Botella J; Paris J
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):407-12. PubMed ID: 7626488
[TBL] [Abstract][Full Text] [Related]
4. Effects of Org OD14 (Livial) and its metabolites on 17 beta-hydroxysteroid dehydrogenase activity in hormone-dependent MCF-7 and T-47D breast cancer cells.
Chetrite GS; Kloosterboer HJ; Philippe JC; Pasqualini JR
Anticancer Res; 1999; 19(1A):261-7. PubMed ID: 10226552
[TBL] [Abstract][Full Text] [Related]
5. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
6. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
Chetrite GS; Thole HH; Philippe JC; Pasqualini JR
Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306
[TBL] [Abstract][Full Text] [Related]
7. Progestins and breast cancer.
Pasqualini JR
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():32-41. PubMed ID: 17943537
[TBL] [Abstract][Full Text] [Related]
8. Effect of Org OD14 (LIVIAL) and its metabolites on human estrogen sulphotransferase activity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines.
Chetrite GS; Kloosterboer HJ; Philippe JC; Pasqualini JR
Anticancer Res; 1999; 19(1A):269-75. PubMed ID: 10226553
[TBL] [Abstract][Full Text] [Related]
9. Control of sulfatase activity by nomegestrol acetate in normal and cancerous human breast tissues.
Chetrite GS; Thomas JL; Shields-Botella J; Cortes-Prieto J; Philippe JC; Pasqualini JR
Anticancer Res; 2005; 25(4):2827-30. PubMed ID: 16080533
[TBL] [Abstract][Full Text] [Related]
10. Control and expression of oestrone sulphatase activities in human breast cancer.
Pasqualini JR; Chetrite G; Nestour EL
J Endocrinol; 1996 Sep; 150 Suppl():S99-105. PubMed ID: 8943793
[TBL] [Abstract][Full Text] [Related]
11. Effect of nomegestrol acetate on human estrogen sulfotransferase activity in the hormone-dependent MCF-7 and T-47D breast cancer cell lines.
Chetrite GS; Paris J; Shields-Botella J; Philippe JC; Pasqualini JR
Anticancer Res; 2003; 23(6C):4651-5. PubMed ID: 14981909
[TBL] [Abstract][Full Text] [Related]
12. Effect of tibolone (Org OD14) and its metabolites on estrone sulphatase activity in MCF-7 and T-47D mammary cancer cells.
Chetrite G; Kloosterboer HJ; Pasqualini JR
Anticancer Res; 1997; 17(1A):135-40. PubMed ID: 9066643
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer and steroid metabolizing enzymes: the role of progestogens.
Pasqualini JR
Maturitas; 2009 Dec; 65 Suppl 1():S17-21. PubMed ID: 19962254
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
Selcer KW; Hegde PV; Li PK
Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848
[TBL] [Abstract][Full Text] [Related]
15. The selective estrogen enzyme modulators in breast cancer: a review.
Pasqualini JR
Biochim Biophys Acta; 2004 Jun; 1654(2):123-43. PubMed ID: 15172700
[TBL] [Abstract][Full Text] [Related]
16. Transformation of estrone and estradiol in hormone-dependent and hormone-independent human breast cancer cells. Effects of the antiestrogen ICI 164,384, danazol, and promegestone (R-5020).
Nguyen BL; Chetrite G; Pasqualini JR
Breast Cancer Res Treat; 1995 May; 34(2):139-46. PubMed ID: 7647331
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of progestins on breast tissue enzymes.
Pasqualini JR
Maturitas; 2003 Dec; 46 Suppl 1():S45-54. PubMed ID: 14670645
[TBL] [Abstract][Full Text] [Related]
18. Progestins in the menopause in healthy women and breast cancer patients.
Pasqualini JR
Maturitas; 2009 Apr; 62(4):343-8. PubMed ID: 19179024
[TBL] [Abstract][Full Text] [Related]
19. The regulation and inhibition of 17beta-hydroxysteroid dehydrogenase in breast cancer.
Purohit A; Tutill HJ; Day JM; Chander SK; Lawrence HR; Allan GM; Fischer DS; Vicker N; Newman SP; Potter BV; Reed MJ
Mol Cell Endocrinol; 2006 Mar; 248(1-2):199-203. PubMed ID: 16414180
[TBL] [Abstract][Full Text] [Related]
20. Effect of nomegestrol acetate on estrone-sulfatase and 17beta-hydroxysteroid dehydrogenase activities in human breast cancer cells.
Chetrite G; Paris J; Botella J; Pasqualini JR
J Steroid Biochem Mol Biol; 1996 Aug; 58(5-6):525-31. PubMed ID: 8918978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
